![Sebastian Wehle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sebastian Wehle
Direktor/Vorstandsmitglied bei TIGENIX NV
Ursprung des Netzwerks ersten Grades von Sebastian Wehle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
10
| Holding Company | Medical Specialties | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sebastian Wehle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO General Counsel | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree | |
OncoDNA SA
![]() OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Abbott Medical Optics Spain SL | Human Resources Officer | ||
Genetrix SL
![]() Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Leids Universitair Medisch Centrum
![]() Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
![]() GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hasselt University | College/University | Doctorate Degree | |
Arcarios NV | Director/Board Member | ||
New York University School of Law | College/University | Graduate Degree | |
New York State Bar Association
![]() New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NYXOAH SA | Medical Specialties | General Counsel | |
Instituto de Empresa SL | College/University | Graduate Degree | |
Aries Complex SA
![]() Aries Complex SA Aerospace & DefenseElectronic Technology Aries Complex, a leading company of Aries Group, in the Aerospace field is specialized in manufacturing and assembly of composite components structures for the Aerospace Industry. Aries Complex was established in 1986 and has since then continuously developed its capacities and technical abilities along the whole aerospace production line (engineering, manufacturing and service) implementing competitive and innovating solutions. Aries Complex provides continuous support to all aerospace customers, assuring services with global focusing on its requirements and initiating the collaboration at the very first launching stage of the project. Aries Complex provides services throughout the entire manufacturing chain from design to the assembled delivery and customer support (stress, design, design & tool manufacturing, production engineering, manufacturing, components procedure, assembly, surface finish & painting, test & certifications and customer support). | Aerospace & Defense | Human Resources Officer | |
JJ Surgical Vision Spain SL
![]() JJ Surgical Vision Spain SL Medical DistributorsDistribution Services Part of Johnson & Johnson, JJ Surgical Vision Spain SL is a Spanish company that retails medical, optical, orthopedic and photographic instruments. The company is based in Madrid, Spain. | Medical Distributors | Human Resources Officer | |
Universitat Autònoma de Barcelona | College/University | Graduate Degree | |
Universidad Complutense de Madrid | College/University | Graduate Degree | |
BePharBel Manufacturing SA
![]() BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
BIOSENIC SA | Biotechnology | Director/Board Member | |
Gsk Biologicals
![]() Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
Vaxxilon AG
![]() Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member | |
BESIX Group NV
![]() BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Director/Board Member | |
BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member | |
GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member | |
IBA SA
![]() IBA SA Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, IBA SA is a French company that manufactures and distributes air care and cleaning products. The company is based in Maisons Alfort, France. | Household/Personal Care | Director/Board Member | |
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Corporate Officer/Principal | |
Asociacion De Empresas Biotecnologicas
![]() Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Biotechnology | Director/Board Member | |
Consejo Superior de Investigaciones Científicas | College/University | Doctorate Degree | |
INSEAD | College/University | Masters Business Admin | |
Engitix Therapeutics Ltd. | Chairman | ||
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Smithkline Beecham Holdings Corp.
![]() Smithkline Beecham Holdings Corp. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beecham Holdings Corp. produces and distributes pharmaceutical products and dental healthcare products. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | President | |
Alliance for Advanced Therapies
![]() Alliance for Advanced Therapies Medical/Nursing ServicesHealth Services The Alliance for Advanced Therapies’ mission is to improve the legislative, business and science climate for advanced therapies innovation in Europe. In order to do so, AAT promotes the interests of its members and the advanced therapies sector in Europe. AAT coordinates input to, and exchanges information with relevant European authorities. The Alliance also increases awareness of the sector among all relevant stakeholders, with a special focus on investors. Furthermore, AAT promotes increased funding for the sector from public and private sources. | Medical/Nursing Services | Chairman | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Tigenix SAU
![]() Tigenix SAU Medical SpecialtiesHealth Technology Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors. | Medical Specialties | Chief Executive Officer | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Colegio Universitario de Estudios Financieros | College/University | Masters Business Admin | |
University of Granada | College/University | Undergraduate Degree | |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Bocconi | College/University | Doctorate Degree | |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sensia SL | Director/Board Member |
Statistik
International
Belgien | 16 |
Spanien | 15 |
Vereinigte Staaten | 6 |
Frankreich | 5 |
Niederlande | 4 |
Sektoral
Health Technology | 19 |
Consumer Services | 12 |
Commercial Services | 7 |
Health Services | 5 |
Finance | 4 |
Operativ
Director/Board Member | 23 |
Corporate Officer/Principal | 15 |
Chief Executive Officer | 9 |
Chairman | 5 |
General Counsel | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Sebastian Wehle
- Unternehmensverbindungen